20
4
1
49
Cat. No. | Product Name | ||
---|---|---|---|
L8720 | 细胞焦亡化合物库 | 1066 compounds | |
1066 种细胞焦亡相关的化合物,可以用于细胞焦亡相关研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15622 |
JNJ-54175446
JNJ-5446 |
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
JNJ-54175446 (JNJ-5446) 是一种具有中枢神经系统渗透性和选择性的 P2X7 受体拮抗剂,可减弱小胶质细胞 IL-1β/IL-18 的释放,可用于研究抑郁症。 | |||
T36347 |
Ac-YVAD-CMK
Caspase-1 Inhibitor II,Ac-Tyr-Val-Ala-Asp-chloromethylketone,Ac-Tyr-Val-Ala-Asp-CMK |
IL Receptor; Caspase; Immunology/Inflammation related; Pyroptosis | Apoptosis; Immunology/Inflammation; Proteases/Proteasome |
Ac-YVAD-CMK (Ac-Tyr-Val-Ala-Asp-CMK) 是一种选择性的、不可逆的Caspase-1抑制剂,并能抑制焦亡作用、IL-1β和IL-18。Ac-YVAD-CMK 显示出神经保护和抗炎的能力。 | |||
T6090 |
Belnacasan
VX-765 |
Caspase | Apoptosis; Proteases/Proteasome |
Belnacasan (VX-765) 是一种具有口服活性的 IL 转换酶/caspase-1 抑制剂,是 VRT-043198 的口服生物活性前药,作用于外周血单核细胞,可抑制 LPS 诱导的 IL-1β 和 IL-18 释放。 | |||
TP2008L |
Lyn peptide inhibitor acetate
Lyn peptide inhibitor acetate(222018-18-0 free base) |
IL Receptor | Immunology/Inflammation |
Lyn peptide inhibitor acetate(222018-18-0 free base) 是一种有效的细胞渗透性 Lyn 偶联 IL-5 受体信号通路抑制剂,同时保持其他信号完整。它阻断 Lyn 活化并抑制 Lyn 酪氨酸激酶与 IL-3/GM-CSF/IL-5 受体的 βc 亚基的结合。它可用于哮喘、过敏和其他嗜酸性粒细胞疾病的研究。 | |||
T16570 |
Pralnacasan
VX-740,HMR 3480 |
Others | Others |
Pralnacasan inhibits proinflammatory cytokines IL-18, IL-1β , and IFN-γ. Pralnacasan is an effective, non-peptide, and orally active interleukin-1β converting enzyme inhibitor (Ki: 1.4 nM). Pralnacasan has the potential for osteoarthritis and rheumatoid a | |||
T70905 |
TLR9-IN-18
|
||
TLR9-IN-18 is a potent and selective TLR9 antagonist. TLR9-IN-18 suppresses the production of the proinflammatory cytokine IL-6 in a CpG-induced mouse model. | |||
T81668 |
NLRP3 agonist 1
|
NOD-like Receptor (NLR) | Immunology/Inflammation |
NLRP3 agonist1 (compound 23)为高效口服活性NLRP3激动剂。该化合物能够激活Caspase-1酶,进而将pro-IL-1β与pro-IL-18等促炎细胞因子裂解为成熟型态。 | |||
T76938 | Camoteskimab | ||
Camoteskimab (AVTX-007)为全人源、高亲和力抗IL-18单克隆抗体,展现于自身炎症性疾病研究潜力,包括成人斯蒂尔病(AOSD)。 | |||
T10447 |
BAA473
|
Others | Others |
BAA473 是胆汁酸类似物,是一种强效的吡喃类炎症小体激活剂。BAA473可通过激活髓样和肠上皮细胞中的炎症小体来诱导白细胞介素( IL-18 )的分泌。 | |||
T78822 |
JT002
|
NOD-like Receptor (NLR) | Immunology/Inflammation |
JT002为口服活性的NLRP3炎性体抑制剂,能够抑制NLRP3依赖性促炎细胞因子(如IL-1β、IL-1α、IL-18)的生成以及细胞焦亡(pyroptosis),阻断NLRP3炎性体复合物的形成。此外,JT002可有效减少小鼠气道高反应性,并降低气道中中性粒细胞的聚集。 | |||
T61621 |
IMMH001
|
||
IMMH001, also known as SYL930, is an orally active compound that exhibits potent selectivity as an agonist for the S1P1 receptor, which is the sphingosine-1-phosphate receptor 1. This compound effectively reduces the levels of various chemokines and proinflammatory cytokines, such as IL-1β, IL-5, IL-18, IP10, CCL3, and CCL5. IMMH001 finds utility in research focused on rheumatoid arthritis (RA) [1] [2]. | |||
T68225 |
Fc 11a-2
|
||
Fc 11a-2 是一种苯并咪唑化合物,一种具有口服活性且有效的NLRP3炎症小体 (NLRP3inflammasome) 抑制剂。Fc 11a-2 通过抑制caspase-1的激活进而抑制 IL-1b/IL-18 的激活来抑制NLRP3炎性体的形成。Fc 11a-2 可防止Dextran sulfate sodium(DSS) 诱导的小鼠实验性结肠炎。 | |||
T81579 | P2X7 receptor antagonist-4 | ||
P2X7 receptor antagonist-4(Compound 14a)是一种选择性P2X7R拮抗剂,其对人类和小鼠P2X7R的IC50值分别为64.7 nM和10.1 nM。该化合物能有效抑制NLRP3炎性体的激活,并在脓毒症模型小鼠中减少肾损伤,降低caspase-1、gasdermin D、IL-1β和IL-18的表达。 | |||
T37458 |
C18 Phytoceramide (t18:0/18:0)
|
||
C18 Phytoceramide (t18:0/18:0) (Cer(t18:0/18:0)) is a bioactive sphingolipid found in S. cerevisiae, wheat grains, and the stratum corneum layer of mammalian epidermis. Cer(t18:0/18:0) is composed of a phytosphingosine backbone amine-linked to a C18 fatty acid chain. Cer(t18:0/18:0) has a role in regulation of apoptosis, cell differentiation, proliferation of smooth muscle cells, and inhibition of the mitochondrial respiratory chain. It also inhibits expression of the allergic cytokines IL-4, TN... | |||
T74908 |
ODN 2336
|
||
ODN 2336 是 A 类 CpG ODN(寡脱氧核苷酸),是一种有效的 TLR9激动剂。ODN 2336 诱导 IFN-α 的产生。ODN 2336 上调 IP-10 mRNA 和 IL-18mRNA 的表达。ODN 2336 可用作疫苗的佐剂。 | |||
T36320 |
C6 L-threo Ceramide (d18:1/6:0)
C6 L-threo Ceramide (d18:1/6:0) |
||
C6 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 L-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlike C6 L-erythro ceramide , C6 L-threo ceramide cannot be converted to C6 glucosylceramide by ceramide glucosyltransferase. C6 L-threo Ceramide enhances IL-4 production induced by phorbol 12-myristate 13-acetate in EL4 T cells when used at a concentration of 10 μM. | |||
T37565 |
C6 D-threo Ceramide (d18:1/6:0)
C6 D-threo Ceramide (d18:1/6:0) |
||
C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlike C6 L-erythro ceramide , C6 D-threo ceramide cannot be converted to C6 glucosylceramide by ceramide glucosyltransferase. C6 D-threo Ceramide promotes survival of isolated rat spinal neurons when used at concentrations up to 2.5 μM but induces cell death at concentrations greater... | |||
T69815 |
SB-284851-BT
|
||
SB-284851-BT 是一种 BRD4/p38α/BRDT 抑制剂。SB-284851-BT 抑制BRD4-BD1(IC50=1.7 µM)、p38α(Kd=0.47 nM)、BRDT(1) (IC50=18 µM) 和BRD4(1) (IC50=3.7 µM)。SB-284851-BT 通过抑制p38α以减少IL-8的产生,抑制BRD4以下调癌症的c-Myc 和NF-κB 基因通路。SB-284851-BT 能与溴结构域和超末端结构域 (BET) 结合。 | |||
T36629 | Givinostat | ||
Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat (ITF2357) suppresses total LPS-induced IL-1β production robustly compared with the reduction by ITF3056. At 25, 50, and 100 nM, Givinostat reduced IL-1β secretion more than 70%. Givinostat (ITF-2357) suppresses the production of IL-6 in PBMCs stimulated with TLR agonists as well as the combination of IL-12 plus IL-18. IL-6 secretion decreases to 50% at 50 nM Givinostat, but at 1... | |||
T37614 |
LDN-0088050
|
||
LDN 0088050 is selectivity adipocyte fatty acid binding protein (AFABP, FABP4) inhibitor with Ki values of 0.29 and 1.3 μM for FABP4 and FABP3, respectively. LDN 0088050 binds to FABP4 with a Kd of 2.05 μM[1]. Ki: 0.29 μM (FABP4), 1.3 μM (FABP3)[1]Kd: 2.05 μM (FABP4)[1] LDN 0088050 significantly inhibits LPS-induced expression of both TNFα and IL-6 in RAW264.7 cells[1]. [1]. Zhou Y, et al. The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biolo... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9352 |
hydrocotarnine
|
Others | Others |
hydrocotarnine 是 Cbl 的抑制剂。 | |||
T37280 |
PE(18:1(9Z)/0:0)
|
Endogenous Metabolite | Metabolism |
PE(18:1(9Z)/0:0) 是一种天然存在的溶血磷脂,是缩醛磷脂溶血磷脂酰乙醇胺的类似物。 PE(18:1(9Z)/0:0) 以浓度依赖性方式诱导 PC12 大鼠神经元细胞中细胞内钙的瞬时增加。 PE(18:1(9Z)/0:0) 增加 IL-4 和 IL-2 的产生,但不增加 IFN-γ 的产生。 在小鼠血清中,PE(18:1(9Z)/0:0)(1 μg/动物)诱导 T 辅助细胞 2 反应。 在寒冷暴露三天后,小鼠肩胛间棕色脂肪组织中的 PE(18:1(9Z)/0:0) 水平增加。 | |||
T7009 |
Soyacerebroside II
|
IL Receptor; Calcium Channel | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism |
Soyacerebroside II exhibits ionophoretic activity for Ca2+ ion. Soyacerebrosides I and II have modulating the cellular immune response effects, they show obvious inhibitory activity on IL-18 secretion in human peripheral blood mononuclear cells (PBMC). | |||
T38838 |
QS-21
Stimulon,QS-21 |
||
QS-21, an immunostimulatory saponin, is a powerful vaccine adjuvant that stimulates both Th2 humoral and Th1 cell-mediated immune responses by interacting with antigen presenting cells (APCs) and T cells. Additionally, QS-21 activates the NLRP3 inflammasome, leading to the release of cytokines IL-1β and IL-18, which are dependent on caspase-1. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00277 |
IL-18 Protein, Human, Recombinant
IGIF,IL-18,IL1F4,IL-1g,I... |
Human | E. coli |
IL-18 Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18.2 kDa and the accession number is Q14116-1. | |||
TMPY-03273 |
IL-18 Protein, Mouse, Recombinant
interleukin 18,白细胞介素,白介素,Il-18,Ig... |
Mouse | E. coli |
IL-18 Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18.2 kDa and the accession number is P70380-1. | |||
TMPY-03102 |
IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (hFc)
interleukin 18 receptor accessory protein,IL |
Rhesus | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 65.4 kDa and the accession number is XP_001108108.1. | |||
TMPY-01111 |
IL-18BP Protein, Mouse, Recombinant (His)
IL-18BP,MC54L,interleukin 18 bind... |
Mouse | HEK293 Cells |
IL-18BP Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 19.4 kDa and the accession number is Q9Z0M9. | |||
TMPY-05491 |
IL-18R alpha Protein, Human, Recombinant (hFc)
CDw218a,interleukin 18 receptor 1,IL |
Human | HEK293 Cells |
IL-18R alpha Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 62.5 kDa and the accession number is Q13478. | |||
TMPY-01219 |
IL-18R alpha Protein, Human, Recombinant (His)
CDw218a,interleukin 18 receptor 1,IL |
Human | HEK293 Cells |
IL-18R alpha Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.2 kDa and the accession number is Q13478. | |||
TMPY-03381 |
IL-18 Protein, Human, Recombinant (GST)
IL-18,IL-1g,白介素,IGIF,白细胞介素,IL... |
Human | E. coli |
IL-18 Protein, Human, Recombinant (GST) is expressed in E. coli expression system with GST tag. The predicted molecular weight is 48.6 kDa and the accession number is Q14116. | |||
TMPY-01446 |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (His)
IL-18Rbeta,CD218b,IL- |
Human | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 40 kDa and the accession number is O95256-1. | |||
TMPJ-00070 |
IL-18 Protein, Human, Recombinant (His)
GIF,IL-1 γ,白细胞介素,Iboctadekin,Interleukin-18 |
Human | HEK293 Cells |
Interleukin-18 is a secreted protein and it belongs to the IL-1 family. IL-18 is a proinflammatory cytokine and produced by macrophages and other cells. This cytokine can induce the IFN-gamma production of T cells. The combination of this cytokine and IL12 has been shown to inhibit IL-4 dependent IgE and IgG1 production, and enhance IgG2a production of B cells. IL-18 binding protein (IL18BP) can specifically interact with this cytokine, and thus negatively regulate its biological activity. After... | |||
TMPK-00076 |
IL-18 Protein (Primary Amine Labeling), Human, Recombinant, Biotinylated
白介素,IL-18,白细胞介素,IL18, |
Human | E. coli |
Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. | |||
TMPY-01928 |
IL-18 Protein, Rhesus, Recombinant (His)
白细胞介素,interleukin 18,白介素 |
Rhesus | E. coli |
IL-18 Protein, Rhesus, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.7 kDa and the accession number is Q9BGI5. | |||
TMPJ-01056 |
IL-18 Protein, Mouse, Recombinant (His)
Interferon γ-inducing factor,Interleukin-1 gamma,Igif,IL... |
Mouse | E. coli |
Interleukin-18 (IL-18)is a protein which belongs to the IL-1 family. It is expressed as a 24 kDa precursor by endothelial and epithelial cells, keratinocytes, gamma δ T cells, and phagocytes. Mature mouse IL-18 shares 63% and 91% amino acid sequence identity with mouse and rat IL-18, respectively. IL-18 binds to the widely expressed IL-18 R alpha which recruits IL-18 R beta to form the signaling receptor complex. Its bioactivity is negatively regulated by interactions with IL-18 binding proteins... | |||
TMPK-00317 |
IL-18R alpha Protein, Human, Recombinant (His & Avi), Biotinylated
IL-18 R α,IL-1 R5,IL... |
Human | HEK293 Cells |
Interleukin-18 (IL-18) is a member of the interleukin-1 family of cytokines produced constitutively by different cell types and by adipose tissue. Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. IL-18R alpha Pr... | |||
TMPK-00512 |
IL-18R alpha Protein, Cynomolgus, Recombinant (aa 22-329, His)
IL18R1,IL-1 Rrp,CD218a,<... |
Cynomolgus | HEK293 Cells |
Interleukin-18 (IL-18) is a member of the interleukin-1 family of cytokines produced constitutively by different cell types and by adipose tissue. Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. IL-18R alpha Pr... | |||
TMPK-00316 |
IL-18R alpha Protein, Human, Recombinant (His & Avi)
CD218a,IL-18 R1,IL1RRP,<... |
Human | HEK293 Cells |
Interleukin-18 (IL-18) is a member of the interleukin-1 family of cytokines produced constitutively by different cell types and by adipose tissue. Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. IL-18R alpha Pr... | |||
TMPK-00492 |
IL-18BP Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated
Igifbp,Interleukin-18-binding protein,IL-<... |
Cynomolgus | HEK293 Cells |
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. IL-18BP Protein (Primary Amine Labeling), Cynomolgus, Recombi... | |||
TMPK-00491 |
IL-18BP Protein, Cynomolgus, Recombinant (His)
Igifbp,Interleukin-18-binding protein,IL-<... |
Cynomolgus | HEK293 Cells |
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. IL-18BP Protein, Cynomolgus, Recombinant (His) is expressed i... | |||
TMPY-00609 |
IL-18R beta/IL-18RAP Protein, Mouse, Recombinant (His)
interleukin 18 receptor accessory protein,AcPL,... |
Mouse | Baculovirus Insect Cells |
IL-18R beta/IL-18RAP Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 40.1 kDa and the accession number is Q0VBK3. | |||
TMPY-03103 |
IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (His)
interleukin 18 receptor accessory protein,IL |
Rhesus | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.85 kDa and the accession number is XP_001108108.1. | |||
TMPY-06750 |
IL-18R beta/IL-18RAP Protein, Rabbit, Recombinant (His)
interleukin 18 receptor accessory protein,IL |
Rabbit | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Rabbit, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 40.22 kDa and the accession number is G1SQ92. | |||
TMPY-06761 |
IL-18R beta/IL-18RAP Protein, Rat, Recombinant (His)
interleukin 18 receptor accessory protein,IL |
Rat | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 40.28 kDa and the accession number is A0A0G2K2K7. | |||
TMPY-06316 |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc & Avi), Biotinylated
IL-18Rbeta,IL-18R β/... |
Human | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 67.04 kDa and the accession number is NP_003844.1. | |||
TMPY-06897 |
IL-18R alpha Protein, Human, Recombinant (His), Biotinylated
IL18RA,interleukin 18 receptor 1,... |
Human | HEK293 Cells |
IL-18R alpha Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37.21 kDa and the accession number is NP_003846.1. | |||
TMPY-06312 |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (His & Avi), Biotinylated
ACPL,CDw218b,IL-18RAcP,IL |
Human | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 41.76 kDa and the accession number is NP_003844.1. | |||
TMPY-01200 |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc)
IL-1R-7,IL-1R7,interleukin 18 rec... |
Human | HEK293 Cells |
IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 65.2 kDa and the accession number is O95256-1. | |||
TMPY-06578 |
IL-18R alpha Protein, Human, Recombinant (hFc & Avi), Biotinylated
IL18RA,CDw218a,CD218a, |
Human | HEK293 Cells |
IL-18R alpha Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 64.30 kDa and the accession number is NP_003846.1. | |||
TMPJ-00072 |
IL-18BPd Protein, Mouse, Recombinant (hFc)
Interleukin 18 Binding Protein Isoform d,IL |
Mouse | HEK293 Cells |
Interleukin 18 binding protein (IL-18BP) is a physiological inhibitor that acts through binding to the receptor-binding site of IL-18. IL-18 stimulates INF-γ, which then stimulates 18BP production via NF-κB. The interaction between IL-18 and IL-18BP has a significant role in the inflammation process. IL-18 BPs have four isoforms, a, b, c and d, which are spliced by different ways. The IL-18 BP isoforms a and c each contain one immunoglobulin (Ig)-like C2-type domain which is essential to the bin... | |||
TMPK-00661 |
IL-22 Protein, Cynomolgus, Recombinant (His)
TIFIL-23,IL-22,IL-D110,IL |
Cynomolgus | HEK293 Cells |
The cytokine interleukin-22 (IL-22) is a critical regulator of epithelial homeostasis. It has been implicated in multiple aspects of epithelial barrier function, including regulation of epithelial cell growth and permeability, production of mucus and antimicrobial proteins (AMPs), and complement production. IL-22 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 17.69 kDa and the accession number is G7PHZ7. | |||
TMPY-00844 |
IL-17RD Protein, Human, Recombinant (His)
IL-17RD,interleukin 17 receptor D,HH18, |
Human | HEK293 Cells |
IL-17RD Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 33.5 kDa and the accession number is Q8NFM7-1. | |||
TMPK-01194 |
IL-22 Protein, Mouse, Recombinant (His & Avi), Biotinylated
IL-22,Cytokine Zcyto18,白细胞介素,IL-T... |
Mouse | E. coli |
The cytokine interleukin-22 (IL-22) is a critical regulator of epithelial homeostasis. It has been implicated in multiple aspects of epithelial barrier function, including regulation of epithelial cell growth and permeability, production of mucus and antimicrobial proteins (AMPs), and complement production. IL-22 Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 19.7 kDa and the accession number i... | |||
TMPJ-00344 |
IL-18RAP Protein, Human, Recombinant (hFc & His)
IL-1R accessory protein-like,Interleukin-18 |
Human | HEK293 Cells |
IL-18RAP is a single-pass type I membrane protein and contains two Ig-like C2-type domains and one TIR domain, IL18RAP can be induced by IFN-alpha and IL12 in nature killer cells and T-cells. The coexpression of IL18R1 and IL18RAP is required for the activation of NF-kappa B and JNK in response to IL-18.Defects in IL18RAP are associated with Coeliac disease. | |||
TMPH-00494 |
IL-18 Protein, Canine, Recombinant (His)
|
Canine | E. coli |
IL-18 Protein, Canine, Recombinant (His) is expressed in E. coli. | |||
TMPY-02872 |
IL-36 gamma Protein, Human, Recombinant (aa 18-169)
IL-1H1,IL1RP2,白介素,IL-1F9,IL |
Human | E. coli |
IL-36 gamma Protein, Human, Recombinant (aa 18-169) is expressed in E. coli expression system. The predicted molecular weight is 17 kDa and the accession number is Q9NZH8-1. | |||
TMPY-02852 |
IL-36 gamma Protein, Human, Recombinant (aa 18-169, His)
IL-1H1,IL36 γ,IL1F9,interleukin 3... |
Human | E. coli |
IL-36 gamma Protein, Human, Recombinant (aa 18-169, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 19.1 kDa and the accession number is Q9NZH8-1. | |||
TMPY-00854 |
IL-1 alpha/IL-1A Protein, Human, Recombinant
IL-1F1,interleukin 1, α,interleukin 1, alpha,白介素, |
Human | HEK293 Cells |
IL-1 alpha/IL-1A Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 18 kDa and the accession number is P01583. | |||
TMPY-01738 |
IL-1 alpha/IL-1A Protein, Mouse, Recombinant
interleukin 1, α,IL-1 α/IL1A,interleukin 1... |
Mouse | E. coli |
IL-1 alpha/IL-1A Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18 kDa and the accession number is P01582. | |||
TMPJ-00035 |
IL-4 Protein, Human, Recombinant (His)
Pitrakinra,Binetrakin,B-Cell Stimulatory Factor 1,IL |
Human | HEK293 Cells |
IL-4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 18 KDa and the accession number is P05112. | |||
TMPY-00861 |
IL-33 Protein, Human, Recombinant
IL1F11,C9orf26,NFEHEV,NF-HEV,DVS27,白介素,interleukin ... |
Human | E. coli |
IL-33 Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18 kDa and the accession number is O95760-1. | |||
TMPK-00514 |
IL-18RAP Protein, Cynomolgus, Recombinant (His)
IL-18RAcP,IL-1R7,IL-... |
Cynomolgus | HEK293 Cells |
IL-18RAP, also known as IL-18Rβ or IL-1R7, is component of IL-18 receptor complex and its interactions with IL-18R1 mediate signal transduction initiated by IL-18 although it does not directly bind IL-18 in vitro. | |||
TMPK-00082 |
IL-18BP Protein, Human, Recombinant (His & Avi), Biotinylated
Igifbp,IL-18BP,IL-18BPA |
Human | HEK293 Cells |
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. IL-18BP Protein, Human, Recombinant (His & Avi), Biotinylated... | |||
TMPY-01956 |
IL-36 alpha/IL-1F6 Protein, Mouse, Recombinant
IL1(ε),FIL1(ε),IL36 α/IL... |
Mouse | E. coli |
IL-36 alpha/IL-1F6 Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18 kDa and the accession number is Q9JLA2-1. | |||
TMPK-01036 |
IL-17A Protein, Mouse, Recombinant (His & Avi)
interleukin 17A,IL17A,CTLA-8,IL17,IL |
Mouse | HEK293 Cells |
IL-17A Protein, Mouse, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18 kDa and the accession number is Q62386-1. | |||
TMPJ-00036 |
IL-2 Protein, Human, Recombinant (His & Avi), Biotinylated
IL2,IL-2,白介素,Interleukin-2,Aldesleukin,T-C... |
Human | HEK293 Cells |
IL-2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 16-18 KDa and the accession number is P60568. | |||
TMPK-01037 |
IL-17A Protein, Mouse, Recombinant (His & Avi), Biotinylated
IL17A,interleukin 17A,IL17,CTLA-8,IL |
Mouse | HEK293 Cells |
IL-17A Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18 kDa and the accession number is Q62386-1. | |||
TMPK-00161 |
IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi)
Interleukin-1 beta,IL-1 β,IL-1β,IL |
Human | E. coli |
Interleukin-1 beta (IL-1β) is induced by inflammatory signals in a broad number of immune cell types. IL-1β (and IL-18) are the only cytokines which are processed by caspase-1 after inflammasome-mediated activation. IL-1 signaling activates innate immune cells including antigen presenting cells, and drives polarization of CD4 T cells towards T helper type (Th) 1 and Th17 cells. IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi) is expressed in E. coli expression system with C-His-Avi tag. ... | |||
TMPK-00515 |
IL-1 beta/IL-1F2 Protein, Cynomolgus, Recombinant (His)
Interleukin-1 β,IL-1 beta,IL1B,IL... |
Cynomolgus | E. coli |
Interleukin-1 beta (IL-1β) is induced by inflammatory signals in a broad number of immune cell types. IL-1β (and IL-18) are the only cytokines which are processed by caspase-1 after inflammasome-mediated activation. IL-1 signaling activates innate immune cells including antigen presenting cells, and drives polarization of CD4 T cells towards T helper type (Th) 1 and Th17 cells. IL-1 beta/IL-1F2 Protein, Cynomolgus, Recombinant (His) is expressed in E. coli expression system with C-His tag. The p... | |||
TMPK-00162 |
IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi), Biotinylated
IL-1 β,IL-1β,IL-1 β/IL-1... |
Human | E. coli |
Interleukin-1 beta (IL-1β) is induced by inflammatory signals in a broad number of immune cell types. IL-1β (and IL-18) are the only cytokines which are processed by caspase-1 after inflammasome-mediated activation. IL-1 signaling activates innate immune cells including antigen presenting cells, and drives polarization of CD4 T cells towards T helper type (Th) 1 and Th17 cells. IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in E. coli expression system with C... | |||
TMPY-02597 |
IL-37 Protein, Human, Recombinant
FIL1Z,IL-37,白细胞介素,IL37,IL |
Human | E. coli |
Interleukin 1 family member 7, or interleukin 37 (IL1F7 / IL37 / IL-1H4) is a secretory protein belonging to the Interleukin 1 family. IL-1F7 was localized in human peripheral monocytic cells. It has been localized the expression of IL-1F7b protein in discrete cell populations including plasma cells and tumor cells. These data suggest that IL-1F7 may be involved in immune response, inflammatory diseases, and/or cancer. Through constructing an adenoviral vector that allows high-level expression i... | |||
TMPJ-00789 |
Flagellin Protein, Salmonella Typhimurium, Recombinant
flaF,Phase 1-I flagellin,Flagellin,fliC,hag |
Salmonella typhimurium | E. coli |
Flagellin is the major structural protein monomer of bacterial flagella. Flagellin through binding to its receptor and activation of antigen presenting cells stimulates the innate and adaptive immune responses. Flagellin is used as an effective systemic or mucosal adjuvant to stimulate the immune system. Flagellin is an agonist of Toll-like receptor 5 (TLR5), a pattern recognition receptor (PRR) of the innate immune system expressed on the basolateral surface of intestinal epithelial cells and o... |